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Abstract Raman spectroscopy has been used to determine
the chemical composition of materials for over 70 years.
Recent spectacular advances in laser and CCD camera
technology creating instruments with higher sensitivity and
lower cost have initiated a strong resurgence in the tech-
nique, ranging from fundamental research to process con-
trol methodology. One such area of increased potential is in
tissue engineering and regenerative medicine (TERM),
where autologous cell culture, stem cell biology and growth
of human cells on biomaterial scaffolds are of high
importance. Traditional techniques for the in vitro analysis
of biochemical cell processes involves cell techniques such
as fixation, lysis or the use of radioactive or chemical labels
which are time consuming and can involve the perpetuation
of artefacts. Several studies have already shown the
potential of Raman spectroscopy to provide useful infor-
mation on key biochemical markers within cells, however,
many of these studies have utilised micro- or confocal
Raman to do this, which are not suited to the rapid and non-
invasive monitoring of cells. For this study a versatile fit-
for-purpose Raman spectrometer was used, employing a
macro-sampling optical platform (laser spot size 100 lm at
focus on the sample) to discriminate between different
TERM relevant cell types and viable and non-viable cells.
The results clearly show that the technique is capable of
obtaining Raman spectra from live cells in a non-destruc-
tive, rapid and non-invasive manner, however, in these
experiments it was not possible to discriminate between
different cell lines. Despite this, notable differences were
observed in the spectra obtained from viable and non-viable
cells, showing significant changes in the spectral profiles of
protein, DNA/RNA and lipid cell constituents after cell
death. It is evident that the method employed here shows
significant potential for further utilisation in TERM, pro-
viding data directly from live cells that fits within a quality
assurance framework and provides the opportunity to ana-
lyse cells in a non-destructive manner.
1 Introduction
Tissue Engineering and Regenerative Medicine (TERM) is
a rapidly emerging interdisciplinary field of research
involving the life, physical and engineering sciences that
seeks to replace or regenerate human tissue or organs, to
restore or re-establish normal bodily function [1]. For
regenerative medicine to be successful it requires a capa-
bility to expand relevant cell populations such as Mesen-
chymal stem cells (MSC), Overcoming the economic,
technical, regulatory and quality assurance challenges that
exist as barriers to progress in the area is currently seen as
critical for benefits to reach patients. Of particular interest
here is the ability to monitor cell status (viability and phe-
notype) during culture in a non-destructive, rapid and non-
invasive manner. Currently there are a number of methods
available to monitor the in vitro interactions that occur
between cells with their environment, including those based
on microscopy, immunochemical and molecular biochemi-
cal techniques. However, whereas there is merit in each,
none effectively provide for these core criteria [2]. The
techniques that are routinely used by cell biologists, are
generally invasive, and require fixation of the cells, the use
of molecular probes or lysis of the cells [2, 3]. In the case
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where cell viability and actual phenotype are under inves-
tigation these methods used are obviously destructive and
therefore do not suit circumstances where the expanded cell
cultures are required to be used directly for clinical
implantation. Hence it is necessary to develop alternative
strategies for in situ and non-destructive analysis. To this
end, a number of alternative techniques are currently being
investigated to analyze cells and tissues for tissue engi-
neering, including, surface plasmon resonance (SPR), bio-
luminescence imaging (BI), optical coherence tomography
(OCT), Fourier Transform Infrared Spectroscopy (FTIR)
and Raman Spectroscopy [4]. Of these techniques, Raman
spectroscopy has shown particular promise [2, 3] as evi-
denced by its increasing utility in the life sciences sector in
recent years [5–17]. One of the drivers for this transforma-
tion has been the evolution of the instrumentation to the
stage where the technique’s potential can be realised in
complex solutions. Seminal research by Puppels et al.
demonstrated the efficacy of using Raman Spectroscopy to
investigate live cells without the need for complex in vitro
assays [11]. More recently, microscope based systems
employing a near infrared (NIR) laser source have been
successfully utilized in a range of studies involving living
cells [5–8]. These include investigations into cell death [5,
14], phenotypic identification of cells [7], proliferation [10],
mitosis [13], and differentiation [9]. Although extremely
useful, none of these approaches really lend themselves to
the requirements for in-situ, real-time, rapid and non-inva-
sive monitoring of cells in their current configurations. As
such, this study aims to utilise a versatile fit-for-purpose
Raman optical platform capable of delivering data directly
from live cells that fits within a quality assurance framework
and provides the opportunity to analyse cells in a non-
destructive manner. The purpose of this study was to
examine a series of well characterised cell lines using a
Bench-top Macro-Raman spectrometer with high through-
put screening (HTS) capability. The system in question
would utilise an optical platform with a 100 lm laser spot
size at focus on the sample to investigate the differences
between different cell lines and the effects of cellular death.
2 Materials and methods
2.1 Cell culture
For this work, a range of TERM relevant cell lines were
cultured under their specific culture conditions prior to
investigation using Raman spectroscopy and Immunocy-
tochemistry. All cells were cultured under standard con-
ditions of 37C, and 95% air and 5%CO2 in T75 culture
flasks (Nunc, UK). All reagents used were from Invitrogen,
Paisley, Scotland unless otherwise stated). Immortalised
cell lines were chosen in this case as they have already
been well characterised and represent a suitable benchmark
before proceeding to primary and stem cell lines.
2.1.1 SAOS2 osteosarcoma cell line
The human osteoblast cell line SAOS2 derived from bone
osteosarcoma cells were purchased from ATCC Global
Bioresource Center. The cells were cultured in McCoy’s 5a
medium (modified) with 1.5 mM L-glutamine adjusted to
contain 2.2 g/l sodium bicarbonate. Media was supple-
mented with 15% fetal bovine serum containing 100 units/ml
of penicillin, 100 lg/ml of streptomycin sulphate and
25 lg/ml of amphotericin B.
2.1.2 WS1 human dermal fibroblast cell line
The normal human dermal fibroblast cell line WS1 (CRL-
1502) was purchased from the ATCC (Global Bioresource
Center). Cells were cultured in Minimum Essential Med-
ium (Eagle’s) supplemented with 10% fetal calf serum
containing 100 units/ml of penicillin, 100 lg/ml of strep-
tomycin and 25 lg/ml of amphotericin B. All reagents used
were from Sigma Chemicals Ltd.
2.1.3 Human embryonic lung epithelial L132 cells
Human embryonic lung epithelial L132 cells were pur-
chased from the ATCC Global Bioresource Center were
propagated in Minimum Essential Medium (Eagle) with
2 mM L-glutamine and Earle’s BSS adjusted to contain
1.5 g/l sodium bicarbonate, 0.1 mM non-essential amino
acids, and 1.0 mM sodium pyruvate, supplemented with
10% fetal bovine serum containing 100 units/ml of peni-
cillin, 100 lg/ml of streptomycin sulphate and 25 lg/ml of
amphotericin B.
2.1.4 MG63 cell line
The MG-63 cells derived from an osteosarcoma of a 14-year-
old male were purchased from the ATCC (Global Biore-
source Center). Cells were cultured in Minimum Essential
Medium (MEM) supplemented with 10% fetal calf serum
and antibiotic/antimycotic (penicillin G sodium 100 U/ml,
streptomycin 100 lg/ml, amphotericin B 0.25 lg/ml, (PAA
Laboratories GmbH, Austria).
2.1.5 Immunocytochemistry
In order to ascertain whether the different cell lines were
living or dead, samples of each were cultured on glass
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coverslips under normal conditions until they became pre-
confluent and cell damage was then induced by incubation
of slides with fresh media containing 100 lM Triton X-100
for 24 h. Immunocytochemistry was performed to examine
the morphology of the cells. Briefly, cell cultures were
grown for 24 h following passage and cells rinsed in ice-
cold PBS and fixed and permeabilised in 3.7% Parafor-
maldehyde containing 0.1% Triton X-100 for 20 min at
4C. The cells were then washed in PBS to remove traces
of the PFA (3 9 15 min) prior to staining of the cell actin
cytoskeleton with Alexa Fluor 488 phalloidin probe
(Molecular Probes, Inc. Invitrogen) for 20 min. After
washing twice in PBS (2 9 5 min), the slides were
mounted in glycerol mounting media containing anti-fade,
sealed using nail varnish and the cells were then viewed
using a Carl Zeiss LSM5 Pascal confocal scanning laser
microscope with dual lasers.
2.2 Analysis of the cells
In order to analyse the cells using a Raman spectrometer,
the relevant cell lines were grown to confluence as outlined
in Sect. 2.1. The cells were then trypsinized (0.25% tryp-
sin/EDTA), centrifuged at low speed and re-suspended in
media for 1 hour. After this, the suspension was centri-
fuged at 5,000 rpm in order to produce a cell pellet suitable
for analysis using the Raman spectrometer. As well as
analysing the different cell lines, live cell pellets and cell
pellets that were subjected to Triton X-100 for 24 h (to
induce cell death) were also analysed (as detailed in
Sect. 2.2.1). Cell pellets were placed on fused silica and
analysed immediately using the Raman spectrometer. All
cell lines were analysed in triplicate by utilising the auto-
mated sampling routines available in the Raman spec-
trometer software (Insight, Avalon Instruments, Belfast).
2.2.1 Induction of cell death
In order to induce cell death in cell populations prior to
Raman analysis, samples of the various cell lines in this
study were incubated in 100 lM Triton X-100 for 24 h.
These samples were analysed using Macro-Raman spec-
troscopy (laser spot size of 100 lm) alongside samples of
the different cell lines that were cultured under normal
conditions as outlined previously in Sect. 2.1.
2.2.2 Raman spectroscopy
Raman spectroscopy was performed on the cell pellets
using an Avalon RamanStation, Belfast, Northern Ireland)
equipped with a stabilised 785 nm near-infrared (NIR)
diode laser and an Echelle spectrograph allowing for the
full spectrum to be analysed without any moving parts.
Laser power was 100 mW at the sample. Pellets of each
cell type were analysed in triplicate using an autofocus
routine for each sample to ensure optimal sample posi-
tioning and signal-to-noise ratio. The instrument was
configured for macro-sampling (in order to account for
sample inhomogeneity), allowing the collection of Raman
scattering from a large area (100 lm diameter spot). This
provides the advantage of analysing a large number of
cells at the same time as opposed to micro-Raman spec-
troscopy that analyses only a single cell. Scans were
recorded from 3400 to 250 cm-1 with up to a 60 second
exposure time. The instrument was wavelength calibrated
using a neon source and verified using a polystyrene
secondary standard (American Society for Testing and
Materials (ASTM) E 1840-96). The spectra were also
intensity corrected using the National Institute of Stan-
dards and Technology (NIST) Standard Reference Mate-
rial (SRM) 2241. The Data obtained were processed by
incorporating a systematic multipoint baseline correction
across all spectra using GRAMS AI (Thermo Galactic).
All spectra were normalised using the peak at 1450 cm-1,
which corresponds to C–H vibrations from all the cellular
components [5, 14].
3 Results and discussion
3.1 Cell morphology & immunofluorescence
Prior to Raman analysis the different cell lines cultured in
the T75 flasks were examined using phase contrast
microscopy to ensure that they exhibited typical cell
morphology and that the cell populations were viable.
Figure 1a and c shows typical phase contrast images of
exemplar L132 Lung epithelial cells and SAOS2 osteo-
blast like cells that were cultured under normal conditions
(and in the absence of Triton-X-100). As was the case for
all the cell lines investigated here, the cells exhibited the
expected cell morphology at both pre-confluency and
confluency. However, for those flasks that were treated
with Triton-X-100, the number of adherent cells on the
flask were significantly reduced as is shown in Fig. 1b
and d for the L132 and SAOS2 cell, respectively. There
was also significant rounding and shrinking of the cells
observed here, with a significant number of cells seen to
be floating in the media. This indicates that the Trinton-
X-100 has induced cell death in the population as
compared to those cells not exposed and cultured under
normal conditions.
Further experiments were conducted to ascertain the
viability of the various cell populations (with and without
exposure to Trinton-X-100) using Immunocytochemistry.
All cell types cultured on glass coverslips demonstrated the
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typical cell morphology expected in the absence of Triton-
X-100 at both pre-confluency and confluency as shown in
Fig. 2a and c for the L132 and SAOS2 cell lines, respec-
tively. Immunofluorescence localisation of actin expression
in permeabilised cells demonstrated a distinctive change in
actin cytoskeletal architecture in cells incubated in the
presence of Triton X-100 for 24 h, as shown in Fig. 2b and
d for the L132 and SAOS2 cell lines, respectively. This
provides a clear indication, more so than the phase contrast
images, that the Trinton-X-100 has induced cell death at
24 h. For those cells exposed to the Trinton-X-100, there is
clear evidence of cell smearing and membrane blebbing,
with significant changes in the cell morphology and cell
definition indicative of membrane disruption.
As such, the experiments conducted here provides
confidence that the cells that have been subjected to
Trinton-X-100 are dead, whereas those cells cultured under
normal conditions (without exposure to Trintox-X-100) are
viable and can go forward to be analysed using Raman
Spectroscopy. It should be noted that all cell lines tested
exhibited the same results as those reported here for the
L132 and SAOS2 cell lines using phase contrast micros-
copy and Immunocytochemistry techniques.
3.2 Raman spectroscopy of the different cell lines
Raman spectra for healthy viable cells are shown in
Fig. 3a–d for the L132, WS1, MG63 and SAOS2 cell lines,
respectively. They all indicate significant contributions
from protein, nucleic acid, lipid and carbohydrate compo-
nents and are comparable to those observed previously by
Notingher et al. [5, 14]. These include typical protein
peaks, such as those observed at 645 cm-1 and 854 cm-1
for Tyrosine and 623 cm-1 and 1005 cm-1 for Phenylal-
anine. Other typical protein peaks are observed between
1128–1450 cm-1 and 1600–1660 cm-1 as expected [5, 10,
14]. Peaks indicative of RNA and DNA are clearly
observed at 782, 788, 1095, 1320–1342 and 1572 cm-1, as
would be expected, however, several key peaks corre-
sponding to RNA and DNA were absent from the spectra,
such as those at 897 and 1013 cm-1 [5, 14, 17]. Lipid
peaks are also observed in all of the spectra for the viable
cells between 1066–1128, 1260–1300, 1449 and
1660 cm-1 [5, 10, 14]. Again, several peaks indicative of
lipids were not clearly observed, particularly those nor-
mally found at 1367 and 1460 cm-1 [5, 14]. The absence
of such peaks could be as a result of numerous factors,
Fig. 1 Phase contrast images for a L132 cell line (no Triton-X-100 exposure), b L132 cell line (Triton-X-100 24 h), c SAOS2 cell line (no
Triton-X-100 exposure), d SAOS2 cell line (Triton-X-100 24 h). (Scale Bar—20 lm)
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including a lack of sensitivity given the optical platform
employed for these experiments, differences due to when
the cells were analysed in their respective cell cycles,
damage to the cells on the outer surface of the pellet, and
problems related to focusing the laser spot on the cell pellet
(or combinations of these factors). Peaks indicative of
carbohydrates can also be seen around 1080–1095 cm-1
[5, 14] along with significant C–H stretching bands (from
mainly lipids and proteins) between 2800 and 3050 cm-1
[10]. The spectra obtained from the different cell lines all
show distinct similarities in the peak positions of their
various cellular components, however, it is important to
note that there are some observable differences in their
spectral profiles. Most notable are those difference seen
around 800–850, 1200–1300 and 1500–1600 cm-1. As
many of these particular areas are associated with protein
and nucleic acid peaks it is suggested that these differences
in the spectra are more likely to be a consequence of the
cells being in different phases of their life cycle as opposed
to observable biochemical differences between different
Fig. 2 Confocal Microscope images for a L132 lung cell line (no Triton-X-100 exposure), b L132 cell line (Triton-X-100 24 h), c SAOS2 cell
line (no Triton-X-100 exposure), d SAOS2 cell line (Triton-X-100 24 h). (Scale Bar—20 lm)
Fig. 3 Raman spectra of viable
cells for a L132 cell line, b WS1
cell line, c MG63 Cell line and
d SAOS2 cell line (Key: Pro—
Protein, Phe—Phenylalanine)
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cell lines. Similar observations were made by Notingher
et al. previously [5, 14, 17]. Indeed, the experiments con-
ducted here were not contrived to ensure that the cells were
at a particular phase of the cell cycle and as such the results
here can only show the spectra of live cells and cannot be
utilised to discriminate between different cell lines.
3.3 Raman spectroscopy for monitoring cell viability
Raman spectra for both the viable and non-viable MG63
Osteoblast like cell line are shown in Fig. 4a and b
respectively. These spectra clearly show significant dif-
ferences between the viable healthy cells (no Trinton-X-
100 treatment) and the non-viable cells (Trinton-X-100
treated) as would have been expected. Notable spectral
differences are observed between 770 and 900 cm-1. Most
of the main peaks observed here for the live cells were not
detected for the Trinton-X-100 treated cells. Normally
peaks in this area are associated with DNA and RNA. In
particular, the peak observed at 788 cm-1, normally asso-
ciated with the O–P–O stretching of DNA phosphodiester
bonds and the peak at 782 cm-1 corresponding to the ring
stretching of cytosine and thyamine [5, 10, 14]. In partic-
ular, the loss of intensity of the O-P-O stretching of DNA
Phosphodiester bonds at 788 cm-1 indicates breaking of
the DNA strands, which is also confirmed by the absence of
the peak at 828 cm-1. The peak at 1572 cm-1 corre-
sponding to DNA and RNA also decreases in intensity after
exposure to Trinton-X-100 which again confirms this
hypothesis. However, no significant decrease was observed
in the phenylalanine peak at 1005 cm-1 or the nucleic acid
peak at 1095 cm-1 as a result of cell death, which has been
previously observed by others [5, 14]. In the case of the
peak at 1095 cm-1, This may be due to the fact that this
peak can also be assigned to lipids, proteins and carbohy-
drates and therefore changes in this particular peak may not
be significant. A significant decrease was observed in the
intensities of those bands associated with proteins between
1280 and 1350 cm-1, which confirms the observations
made previously by Notingher and is a clear indication of
cell death [5, 14]. There was a significant broadening of the
large peak between 1570 cm-1 and 1730 cm-1, particu-
larly on the lower wavenumber side. This could possibly
indicate an increase in the presence of aromatic amino
acids as a result of protein cleavage from cell death.
There was a significant increase in the intensity of peaks
observed between 1020 and 1080 cm-1 as a consequence
of exposure to the Trinton-X-100. Peaks in this area can be
associated with lipids [5, 14]. Further evidence for this
increase in lipid concentration is provided by the increase
in the intensity of the broad band between 1220 and
1300 cm-1 associated with =CH deformations in lipids and
the band at 1660 cm-1 (normally attributed to C=C
stretching) however, other peaks associated with lipids did
not show any significant changes in intensity. This is most
notable for the peak at 1301 cm-1, where no significant
change in intensity was observed. No lipid peak was
observed at 1743 cm-1 for either the live or dead cells in
these experiments as was the case for other published work
[5, 14]. A further peak at 1486 cm-1 was also observed in
the spectrum for the non-viable cells, however, due to the
complex nature of the spectra obtained from the cells it
could not be assigned to a particular cellular component at
this time. In general, the results obtained from the different
cell lines exposed to the Trinton-X-100 solution for 24 h
were very similar to those observed for the MG63 osteo-
blast like cell line and were not considered significant.
The results present here clearly indicate that Raman sys-
tems that are not configured for micro- or confocal Raman
spectroscopy, such as the versatile system employed here,
can be utilised to monitor cell behaviour in real-time and in
non-destructive and non-invasive manner. However, it is
evident from the data obtained here and the observations
from Notingher [5, 14], that in order to clearly discriminate
between different cell lines using such techniques (in a
research context) it would be preferable to ensure that the
Fig. 4 Raman spectra for
a viable MG63 cell line and
b non-viable MG63 cell line
(Key: Pro—Protein, Phe—
Phenylalanine, Ty—Tyrosine,
AA—Amino Acid)
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cells were at the same phase of the cell cycle. In the first
instance it will be important to have benchmark spectra
indicative of a particular cell line at the various phases of
its cell cycle, and to understand the peak assignments
associated with the individual cellular components during
each phase before translating such technology into a clin-
ical or manufacturing setting. However, in a real applica-
tion area, such as the expansion of a cell population for use
in a TERM product, it is unlikely that all of the cells would
be at the same phase of the cell cycle all of the time and as
such, any method used to analyse the cells should be
capable of coping with such situations. Certainly it is
considered that the versatile Raman platform utilised here,
incorporating a larger laser spot size for analysis than
previously published studies is more appropriate for pro-
cess monitoring applications, such as those considered
necessary in the regulatory framework required for TERM
products. The system takes an average spectrum from a
large number of cells rather than analysing individual cells
(or areas within individual cells), and as such is more
representative of the cell population as whole. It also
provides a technique to analyse a larger number of cells
more rapidly than before. Previous authors required spec-
tral acquisition times of between 2 and 10 min per cell,
whereas the approach taken here could analyse multiple
cells in less than 60 s. Indeed, acquisition times of less than
30 s could provide usable spectra from live cells.
A further observation from the analysis of live versus
dead cells shows that the versatile Raman platform utilised
here can easily discriminate between the two cell states.
However, in the experiments conducted here, some of the
key spectral differences that were utilised by previous
authors to discriminate between live and dead cells were
not observed, Most notably, no significant difference was
observed in the intensity of the phenylalanine peak at
1005 cm-1 between the live and dead cells. This is despite
the decrease in intensity of other key peaks associated with
proteins after cell death (1280–1350 cm-1, the increase in
the intensity of some of the key lipid peaks (1020–1080,
1220–1300 and 1660 cm-1) and the loss of key DNA/RNA
peaks (788 cm-1), all being clearly evident. These changes
in the spectral profile for these various cellular components
have all been identified as key Raman spectral markers of
cell death by previous authors [5, 14]. The spectral changes
observed as a result of cell death are the effects of the
complex molecular mechanisms during the induction of
cell death, such as protein cleavage due to the activation of
caspases, followed by DNA fragmentation. As such, the
absence of any significant difference in the peak associated
with phenylalanine (1005 cm-1) after cell death cannot be
taken in isolation, given the other significant differences
observed across the entire spectral profile. Indeed, previous
work by others observed similar instances whereby key
markers of cell viability or non-viability were not observed.
This may be explained by the non-homogeneous distribu-
tion of the various cellular components in the cell pellet or
the fact that the cell population could possibly contain a
significant population of viable cells, despite the exposure
to Trinton-X-100 for 24 h.
4 Conclusion
This study clearly highlights the versatility of using a
Raman spectrometer that incorporates a larger laser spot size
for the analysis of viable cell populations. It is evident from
the work presented here that this can be achieved using a
Raman system that is not microscope based and is suited to
high throughput screening of large populations of cells. The
analysis times are significantly reduced, providing data that
can clearly discriminate between viable and non-viable cell
populations. As yet, the Raman platform utilised here cannot
discriminate between different cell lines, however, further
experimentation is planned in order to address this shortfall
in the technique, including the use of statistical models.
Despite this, the system employed here provided Raman
data in real time, in a non destructive manner and non-
invasive manner (without the need for staining). As yet it is
not optimised for utilisation in a clinical or manufacturing
environment for the expansion of healthy cell populations.
However, it does show significant potential for utilisation in
TERM applications and is the subject of further detailed
investigations by the authors.
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